其它别名Gefitinib Impurity 2; Gefitinib-6; Gefitinib Impurity 5/n-(3-Chloro-4-Fluorophenyl)-6 ,7-Dimethoxyquinazolin-4-Amine; 4-Quinazolinamine, N-(3-Chloro-4-Fluorophenyl)-6,7-Dimethoxy-; Gefitinib Impurity Iiq: What Is Gefitinib Impurity Ii Q: What Is The Cas Number Of Gefitinib Impurity Ii; N-(3-Chloro-4-Fluorophenyl)-6,7-Dimethoxyquinazolin-4-Amine (Gefitinib Impurity)
参考文献:10.1021/jm990345w 摘要:Hennequin LF, Thomas AP, Johnstone C, Stokes ES, Plé PA, Lohmann JJ, Ogilvie DJ, Dukes M, Wedge SR, Curwen JO, Kendrew J, Lambert-van der Brempt C. Design and structure-activity relationship of a new class of potent VEGF receptor tyrosine kinase inhibitors. J Med Chem. 1999 Dec 30;42(26):5369–89. doi: 10.1021/jm990345w.